Hikma Pharmaceuticals PLC Sponsored ADR (HKMPY)

Hikma Pharmaceuticals PLC (HKMPY) Shareholder/Analyst Call Transcript

Hikma Pharmaceuticals PLC (OTCPK:HKMPY) Shareholder/Analyst Call November 6, 2025 4:30 AM EST Company Participants Riad Mishlawi - Interim Head of Injectables Business, CEO & Director Khalid Nabilsi - Chief Financial Officer Conference Call Participants Zain Ebrahim - JPMorgan Chase & Co, Research Division Charlie Haywood - BofA Securities, Research Division Christian Glennie - Stifel, Nicolaus & Company, Incorporated, Research Division Victor Floch - BNP Paribas, Research Division Beatrice Fairbairn - Joh. Berenberg, Gossler & Co. KG, Research Division Kane Slutzkin - Deutsche Bank AG, Research Division James Vane-Tempest - Jefferies LLC, Research Division Sebastien Jantet - Panmure Liberum Limited, Research Division Miles Dixon - Peel Hunt LLP, Research Division Presentation Operator Good day, ladies and gentlemen, and welcome to Hikma November 2025 Trading Update.